- Report
- November 2025
- 450 Pages
Global
From €3507EUR$3,995USD£3,051GBP
- Report
- October 2025
- 1400 Pages
Global
From €4385EUR$4,995USD£3,815GBP
- Report
- January 2026
- 165 Pages
Global
From €4212EUR$4,799USD£3,665GBP
- Report
- February 2025
- 307 Pages
Global
From €4345EUR$4,950USD£3,780GBP
- Report
- April 2025
Global
From €4301EUR$4,900USD£3,742GBP
- Report
- November 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- December 2025
- 150 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- May 2025
- 200 Pages
Global
From €2186EUR$2,490USD£1,902GBP
- Report
- January 2026
- 197 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- January 2026
- 192 Pages
Global
From €3458EUR$3,939USD£3,008GBP
- Report
- October 2025
- 120 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- May 2025
- 137 Pages
Global
From €3510EUR$3,999USD£3,054GBP
- Report
- May 2025
- 130 Pages
Global
From €5223EUR$5,950USD£4,544GBP
- Report
- February 2026
- 218 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- September 2025
- 250 Pages
Global
From €3941EUR$4,490USD£3,429GBP
- Report
- February 2026
- 364 Pages
Global
From €5135EUR$5,850USD£4,467GBP
- Report
- February 2026
- 382 Pages
Global
From €5135EUR$5,850USD£4,467GBP

Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer.
The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more